Last month we kicked off the pilot study on housing and health, set up by the TU Delft | Global Initiative, Leiden Center for Applied Bioscience (LCAB) and LUMC Global in which 6 groups, consisting of students from all institutes, joined forces to analyse the correlation between spatial conditions of residential neighbourhoods and buildings, and health. All groups developed a comparative analysis of two neighbourhoods in The Hague, with each group looking at different neighbourhoods. Last week, on November 10, they presented their findings and suggestions on the central theme: how do we build a pandemic proof and healthy city?
After poster presentations from all student groups, dean Prof Pancras Hogendoorn (LUMC) kicked off the end presentation round at the LUMC by giving a heartfelt introduction to all students. He stressed how valuable this pilot study was to showcase the value of interdisciplinary learning, looking at the same problem from different angles. “A project like this really highlights the things you are really good at and where you need others to fill in gaps in your knowledge”, says Hogendoorn. He closed his introduction emphasizing the importance of follow-up work and research on the urban and health project, to which one of the coordinators, Prof Nelson Mota (TU Delft), added: “This project paves the way for something bigger. We just entered the door of a big building.”
All groups then proceeded to present their work and findings, coming to interesting conclusions to create the pandemic proof and healthy city of the future, considering the influence of residential and urban density, dwelling space, biodiversity and greenery in, around and on buildings, social distance, infrastructure, outdoor air microbiodiversity and ventilation, natural light, urban form, hygiene, lifestyle, safety and mental health. A very elaborate list, although we probably missed some elements the students mentioned given how precise they went about the central problem. Even though all students worked with small samples and stated no significant conclusions could be drawn as a result, they were clearly on to something, matching exactly with the professors’ expectations and desire for follow-up research and practical work.
All in all, the five-week pilot study proved invaluable to both students and professors. The course acts as an important starting point for future collaborations between TU Delft, LUMC and LCAB, and their students. Hopefully next year, we can expand our efforts internationally (which, due to COVID-19, was not possible this year) to give the subject the substance it deserves.
To all who helped set this up, thank you! But most of all to all the students who joined and presented such wonderful work, thank you very much!
The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.
The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.
“This is an achievement in alignment with the mission of VODAN-Africa to generate continuous, real-time, high velocity clinical observational patient data from resource-limited communities that have not been well represented in digital health data. The key feature is that the data produced remains in the health facility only. It will not leave the health facility. Since the data is machine-actionable the input of the data only happens once; in the deployable architecture, the data is used for four parallel use cases” (VODAN to Africa, 2022).